7,4'-Dihydroxy-3'-prenylflavanCAS# 376361-96-5 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 376361-96-5 | SDF | Download SDF |
| PubChem ID | 10990534 | Appearance | Powder |
| Formula | C20H22O3 | M.Wt | 310.4 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S)-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-3,4-dihydro-2H-chromen-7-ol | ||
| SMILES | CC(=CCC1=C(C=CC(=C1)C2CCC3=C(O2)C=C(C=C3)O)O)C | ||
| Standard InChIKey | HORNIGLAKNPZGF-IBGZPJMESA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. 7,4'-Dihydroxy-3'-prenylflavan has antibacterial activity. |
| Targets | Antifection |
7,4'-Dihydroxy-3'-prenylflavan Dilution Calculator
7,4'-Dihydroxy-3'-prenylflavan Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2216 mL | 16.1082 mL | 32.2165 mL | 64.433 mL | 80.5412 mL |
| 5 mM | 0.6443 mL | 3.2216 mL | 6.4433 mL | 12.8866 mL | 16.1082 mL |
| 10 mM | 0.3222 mL | 1.6108 mL | 3.2216 mL | 6.4433 mL | 8.0541 mL |
| 50 mM | 0.0644 mL | 0.3222 mL | 0.6443 mL | 1.2887 mL | 1.6108 mL |
| 100 mM | 0.0322 mL | 0.1611 mL | 0.3222 mL | 0.6443 mL | 0.8054 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 5,7,2',4'-Tetrahydroxy-3-geranylflavone
Catalog No.:BCN1451
CAS No.:376361-87-4
- Maraviroc
Catalog No.:BCC3675
CAS No.:376348-65-1
- Furaltadone HCl
Catalog No.:BCC4662
CAS No.:3759-92-0
- Varenicline tartrate
Catalog No.:BCN2170
CAS No.:375815-87-5
- Phorbol 12,13-dibutyrate
Catalog No.:BCC7870
CAS No.:37558-16-0
- Boc-N-Me-Phe-OH
Catalog No.:BCC2615
CAS No.:37553-65-4
- Boc-Ala(4-pyridyl)-OH
Catalog No.:BCC3326
CAS No.:37535-57-2
- 7'(Z)-(8''R,8'''R)-epi-salvianolic acid E
Catalog No.:BCC3319
CAS No.:
- 3-(2-Pyridyl)-D-Alanine
Catalog No.:BCC2655
CAS No.:37535-52-7
- H- Ala(2-pyridyl)-OH.2HCl
Catalog No.:BCC3318
CAS No.:37535-51-6 net
- 3-(2-Pyridyl)-Alanine
Catalog No.:BCC2656
CAS No.:37535-51-6
- H-D-Ala(4-pyridyl)-OH.HCl
Catalog No.:BCC3325
CAS No.:37535-49-2
- 4'-O-Demethylbroussonin A
Catalog No.:BCN7364
CAS No.:376361-97-6
- 1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxy-3-prenylphenyl)propane
Catalog No.:BCN1450
CAS No.:376362-03-7
- BRD 7389
Catalog No.:BCC8090
CAS No.:376382-11-5
- LY450108
Catalog No.:BCC1725
CAS No.:376594-67-1
- 8-Acetonyldihydrosanguinarine
Catalog No.:BCN5429
CAS No.:37687-34-6
- SU 9516
Catalog No.:BCC2398
CAS No.:377090-84-1
- Dehydroabietinol
Catalog No.:BCN5430
CAS No.:3772-55-2
- Totaradiol
Catalog No.:BCN5431
CAS No.:3772-56-3
- Rhodojaponin V
Catalog No.:BCN2807
CAS No.:37720-86-8
- Boc-Cha-OH
Catalog No.:BCC2661
CAS No.:37736-82-6
- 2-Chloro-N6-cyclopentyladenosine
Catalog No.:BCC7161
CAS No.:37739-05-2
- Questin
Catalog No.:BCN7446
CAS No.:3774-64-9
Aromatase inhibitors from Broussonetia papyrifera.[Pubmed:11678652]
J Nat Prod. 2001 Oct;64(10):1286-93.
Bioassay-guided fractionation of an ethyl acetate-soluble extract from the whole plants of Broussonetia papyrifera, using an in vitro aromatase inhibition assay, led to the isolation of five new active compounds, 5,7,2',4'-tetrahydroxy-3-geranylflavone (1), isogemichalcone C (8), 3'-[gamma-hydroxymethyl-(E)-gamma-methylallyl]-2,4,2',4'-tetrahydroxychalcone 11'-O-coumarate (9), demethylmoracin I (10), and (2S)-2',4'-dihydroxy-2' '-(1-hydroxy-1-methylethyl)dihydrofuro[2,3-h]flavanone (11), and 10 known (12-21) compounds which were also found to be active. Of these compounds, the most potent were 9 (IC(50) 0.5 microM), 11 (IC(50) 0.1 microM), isolicoflavonol (12, IC(50) 0.1 microM), and (2S)-abyssinone II (13, IC(50) 0.4 microM). Additionally, six new compounds, 5,7,3',4'-tetrahydroxy-6-geranylflavonol (2), 5,7,3',4'-tetrahydroxy-3-methoxy-6-geranylflavone (3), (2S)-7,4'-dihydroxy-3'-prenylflavan (4), 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)propane (5), 1-(2,4-dihydroxy-3-prenylphenyl)-3-(4-hydroxyphenyl)propane (6), and 1-(4-hydroxy-2-methoxyphenyl)-3-(4-hydroxy-3-prenylphenyl)propane (7), were isolated and characterized, but proved to be inactive as aromatase inhibitors, as were an additional 21 known compounds. The structures of the new compounds (1-11) were elucidated by spectroscopic methods. Structure-activity relationships in the aromatase assay were determined for the benzofurans, biphenylpropanoids, coumarins, and various types of flavonoids (chalcones, flavans, flavanones, and flavones) obtained among a total of 42 constituents of B. papyrifera.
